Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02423330 · ClinicalTrials.gov registry record · Early Phase 1
A Prospective Evaluation of the Strattice-LIFT to Treat Anal Fistula
A Early Phase 1 study, sponsored by Rush University Medical Center.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 1
- Enrollment target
NCT02423330: Clinical Trial Early Phase 1 study, sponsored by Rush University Medical Center.
NCT02423330 is a Early Phase 1 study that was terminated before completion, run by Rush University Medical Center. The registered enrollment target is 1 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02423330, a Early Phase 1 study, was terminated before completion, sponsored by Rush University Medical Center.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
This clinical trial will evaluate the safety and efficacy of the Strattice-LIFT procedure to treat anal fistulas.
Primary Outcome
Healing is defined as the combination of patient reported lack of drainage and surgeon reported closure of the external opening
Interventions
- DEVICE Strattice-LIFT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2014-09 |
| Est. Completion | 2017-08 |
| Phase | Early Phase 1 |
Why NCT02423330 stopped before completion
NCT02423330 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Strattice-LIFT is the first listed.
NCT02423330 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02423330 about?
NCT02423330 is a clinical study titled "A Prospective Evaluation of the Strattice-LIFT to Treat Anal Fistula". This clinical trial will evaluate the safety and efficacy of the Strattice-LIFT procedure to treat anal fistulas.
What is the current status of trial NCT02423330?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 1 participants. The study started on 2014-09. Estimated completion is 2017-08.
What interventions are being tested in trial NCT02423330?
The interventions under investigation include: Strattice-LIFT (DEVICE).
Who is sponsoring clinical trial NCT02423330?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02423330's enrollment target sits among peer trials
1 1985th of 2000 the lowest of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia